The US is the bigger Brain Imaging, Biomarkers and NeuroInformatics market: $286 Mn against $55 Mn in 2023, about 5.2 times as large.
China grows faster: 6.2% a year, against 2.7%. The gap still grows from $231 Mn to $273 Mn by 2033.
Clinical research: 1,708 active trials in the US, 812 in China.
| Measure |  US |  China |
|---|---|---|
| Market size, 2023 | $286 Mn | $55 Mn |
| Market size, 2033 projected | $373 Mn | $100 Mn |
| Growth a year (CAGR) | 2.7% | 6.2% |
| Money added, 2023–2033 | $87 Mn | $45 Mn |
| Share of the world market | 42% | 8% |
| Size rank of 24 countries | #1 | #2 |
| Market per person, 2023 | $0.84 | $0.04 |
| Active clinical trials | 1,708 | 812 |
| Full report | US report | China report |
Year by year, 2023 to 2033
US China · values between 2023 and 2033 are projected from the 2023 size and the CAGR.
Quick answers
Which is bigger in Brain Imaging, Biomarkers and NeuroInformatics, US or China?
The US is the bigger Brain Imaging, Biomarkers and NeuroInformatics market: $286 Mn against $55 Mn in 2023, about 5.2 times as large.
Which grows faster in Brain Imaging, Biomarkers and NeuroInformatics, US or China?
China grows faster: 6.2% a year, against 2.7%. The gap still grows from $231 Mn to $273 Mn by 2033.
More Brain Imaging, Biomarkers and NeuroInformatics comparisons
Sources: market size and growth: Acuitas Health Analytics research (2023 base year, forecasts to 2033). Trials: ClinicalTrials.gov (fetched 10 Nov 2026); found by search words, so counts are a guide. Population: World Bank.